FDA roadmap to reducing animal testing – A new regulatory era

9 Sept 2025

Since the FDA outlined a 3–5-year ambition to make animal studies the exception rather than the rule, the use of New Approach Methodologies (NAMs) are gaining widespread regulatory adoption.

Find out more about the large number of resources BioIVT provides for NAM submissions, and how it offers a suite of human-derived biospecimens and services to support the initiative to end animal testing.

Links

Tags

Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.FDAThe Food and Drug Association (FDA) is an agency within the U.S. Department of Health and Human Services. Among other things, it is responsible for ensuring the safety, effectiveness and quality of drugs, vaccines and other biological products, and medical devices. Animal TestingImmunoassayImmunoassays are laboratory tests that utilize antibody-antigen interactions to detect specific substances. They are widely used in diagnostics for detecting diseases, drug testing, and environmental monitoring. These assays offer rapid, sensitive, and precise detection of biomarkers, making them invaluable in clinical and research labs. Browse our peer-reviewed product directory to compare immunoassay systems, read user reviews, and get pricing directly from manufacturers.
FDA roadmap to reducing animal testing – A new regulatory era